Trademark Overview
On Wednesday, September 11, 2024, a trademark application was filed for MICRO-TAG with the United States Patent and Trademark Office. The USPTO has given the MICRO-TAG trademark a serial number of 98746046. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 3, 2025. This trademark is owned by NERD BIO, LLC. The MICRO-TAG trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:
Reagents forming a fluorescence-emitting enzyme complementation system for research use; reagents for real-time cellular target engagement assay systems for research use; reagents for therapeutics discovery assays systems using DNA-encoded libraries for research use; chemical preparations for use in science other than for medical or veterinary use; biochemicals for in vitro and in vivo for scientific use; biological tissue cultures other than for medical or veterinary purposes; diagnostic preparations for scientific or research use; in-vivo diagnostic reagents for scientific use; reagents for scientific purposes; chemical substances, namely, chemicals for scientific laboratory use; testing reagents for scientific use; universal reagents for automated test systems for scientific or laboratory research use; universal reagents for automated test systems for scientific use; chemical substances, namely, chemicals for scientific use; enzymes for scientific purposes; enzymes, other than for m...
Research and development services in the field of cellular target engagement, discovery and testing of therapeutics; pharmaceutical drug discovery and development services; research and development in the field of therapeutics discovery; research and development in the field of challenging therapeutic targets; research and development of therapeutics for the treatment of various diseases including cancer; technical research in the field of therapeutics; technology research in the field of challenging therapeutic targets; conducting early evaluations in the field of new therapeutics; pharmaceutical products development of new therapeutic molecules belong to the class of small molecules, molecular glues, degraders, peptides and antibodies; pharmaceutical products development of new therapeutic molecules aimed at inhibiting, degrading or modifying disease-causing cellular proteins for treatment in the field of oncology, immunology, inflammatory diseases, and central nervous system disorde...
